Oncolytics is narrowing Pelareorep development toward anal cancer and metastatic colorectal cancer. Check out why ONCY stock ...
Park National Corporation (Park) (NYSE American: PRK) today reported financial results for the first quarter of 2026. Park's board of directors declared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results